Nixon Peabody represents Swedish Covenant Health in transaction with NorthShore University HealthSystem

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...

Nixon Peabody represented Swedish Covenant Health (SCH) in its agreement to join NorthShore University HealthSystem (NorthShore). The partnership, which closed on January 1, 2020, will preserve local, quality health care for Chicago’s North Side communities, supporting long-term growth and sustainability.

SCH will continue to operate its acute care community hospital, and each health system will maintain its ambulatory and physician care networks. SCH patients will gain access to NorthShore’s advanced specialty services and research programs, among others. NorthShore has also made a substantial contribution to the SCH Foundation, which provides health and wellness programs such as combating homelessness, violence prevention, and dental care.

Nixon Peabody advised SCH throughout the partner selection process, negotiated key transaction documents, and assisted in obtaining all regulatory approvals necessary for the transaction to close. Nixon Peabody’s deal team was led by Health Care partner Tom Fahey and included attorney April Schweitzer.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »